emtricitabine/tenofovir disoproxil fumarate (oral PrEP)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for emtricitabine/tenofovir disoproxil fumarate (oral PrEP), covering 2024-06-21 to 2024-06-21. Get the full timeline:
Most recent: Clinical Trial Update: Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa [Phase 3]